Edwards, Abbott Settle Mitral Repair Patent Cases

Edwards Lifesciences is paying Abbott Laboratories to settle disputes over patents on transcatheter mitral and tricuspid repair products.

Abbott-laboratories

Edwards Lifesciences Corp. has agreed to pay a six-figure sum plus royalties to Abbott Laboratories to settle claims Edwards infringed on Abbott-held patents on transcatheter mitral and tricuspid repair products.

The settlement announced 13 July dismisses all related court and patent office cases worldwide, as well as the lifting of...

More from Legal & IP

More from Policy & Regulation

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By 

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.